FGFR2 and cancer: Aberration of the FGFR2 signaling pathway resulting from gene mutation, overexpression, amplification, or aberrant transcription regulation is related with the tumorigenesis and progression in cancers of the stomach [18], breast [19], bladder [20], and lung [21].